Sid Rubinstein is a Principal in the consulting firm Regulatory Compliance Initiatives, Inc. (RCI), and has more than 30 years experience in the pharmaceutical industry, including over 23 years as a consultant. He specializes in current Good Manufacturing Practice (cGMP) regulations, Quality System requirements, and developing and directing regulatory corrective action initiatives.
As a consultant, Sid founded MediPharm International Consultants, Ltd., a firm specializing in performing audits of US and foreign pharmaceutical manufacturers of active pharmaceutical ingredients, all finished dosage forms, dietary supplements and nutraceuticals, and biotechnology products.
He has successfully prepared domestic and international clients for FDA Pre-Approval Inspections (PAI), and has directed clients in the preparation of Standard Operating Procedure (SOP) and Quality System Manuals, Quality Agreements, and Corrective and Preventative Action (CAPA) Programs.
Sid was also a founder and a Principal in HP BioPharm Technologies, Ltd. and Cox & Fay, Inc., companies dedicated to working with US and foreign firms requiring assistance with drug development and clinical research project management, and with plans for designing new turnkey manufacturing facilities, respectively.
|
|
|
Prior to his consulting career, Sid was Vice President-Operations and Compliance for Dell Laboratories, Inc., Edward Mendell Company, Inc., and The Vitarine Company, Inc.
Sid has a BS degree in Pharmacy from Columbia University College of Pharmaceutical Sciences, and has practiced community pharmacy.
Sidney B. Rubinstein CV |